Literature DB >> 7048218

Ischemic brain injury: the importance of calcium, lipolytic activities, and free fatty acids.

T Wieloch, B K Siesjö.   

Abstract

Ischemic brain insults are accompanied by several metabolic alterations. In the present review, the adverse reactions, which might be important for the outcome of these insults, are those related to phospholipid and polyunsaturated fatty acid metabolism triggered by the disturbed calcium ion homeostasis in combination with energy depletion following ischemia. The conditions lead to an activation of phospholipases and to a decreased rate of phospholipid resynthesis with a concomitant increase in the concentration of free fatty acids, in particular arachidonic acid. During the recirculation phase, when oxygen supply is reestablished, the polyunsaturated arachidonic acid serves as substrate in the cyclo-oxygenase and lipoxygenase pathways leading to the formation of hydroxy-and hydroperoxy fatty acids, prostaglandins and possibly also leukotrienes. These substances have adverse effects on the integrity of cell membranes, irreversibly altering the functional properties of the cells, and also vasomodulator properties influencing the effectiveness of the reperfusion of the brain.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7048218

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  17 in total

1.  Perforated synapses in the neocortex and their role in the reorganization of interneuron interactions in the post-ischemic period.

Authors:  V V Semchenko; S S Stepanov
Journal:  Neurosci Behav Physiol       Date:  1997 Sep-Oct

Review 2.  Mitophagy in ischaemia/reperfusion induced cerebral injury.

Authors:  Kangyong Liu; Yinyi Sun; Zhaohua Gu; Nan Shi; Ting Zhang; Xiaojiang Sun
Journal:  Neurochem Res       Date:  2013-04-07       Impact factor: 3.996

3.  Interstitial glycerol as a marker for membrane phospholipid degradation in the acutely injured human brain.

Authors:  L Hillered; J Valtysson; P Enblad; L Persson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-04       Impact factor: 10.154

4.  Emergency carotid endarterectomy for patients with acute carotid occlusion and profound neurological deficits.

Authors:  F B Meyer; T M Sundt; D G Piepgras; B A Sandok; G Forbes
Journal:  Ann Surg       Date:  1986-01       Impact factor: 12.969

5.  Regulation of the L-type calcium channel alpha-1 subunit by chronic depolarization in the neuron-like PC12 and aortic smooth muscle A7r5 cell lines.

Authors:  O Feron; T Godfraind
Journal:  Pflugers Arch       Date:  1995-07       Impact factor: 3.657

6.  Changes in non-synaptosomal and synaptosomal mitochondrial membrane-linked enzymatic activities after transient cerebral ischemia.

Authors:  C Cafè; C Torri; S Gatti; D Adinolfi; P Gaetani; R Rodriguez Y Baena; F Marzatico
Journal:  Neurochem Res       Date:  1994-12       Impact factor: 3.996

7.  Effect of gallopamil on energy metabolism of the isolated perfused rat brain in the postischemic period.

Authors:  J Weber; J Krieglstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-06       Impact factor: 3.000

8.  Superficial temporal artery--middle cerebral artery anastomosis for acute cerebral ischemia: the effect of small augmentation of blood flow.

Authors:  Y Yoshimoto; S Kwak
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

9.  Cytosolic phospholipase A2 alpha inhibition prevents neuronal NMDA receptor-stimulated arachidonic acid mobilization and prostaglandin production but not subsequent cell death.

Authors:  Ava L Taylor; Joseph V Bonventre; Tracy F Uliasz; James A Hewett; Sandra J Hewett
Journal:  J Neurochem       Date:  2008-06-28       Impact factor: 5.372

Review 10.  Probing the molecular mechanisms of neuronal degeneration: importance of mitochondrial dysfunction and calcineurin activation.

Authors:  Hiroyuki Uchino; Yasuhiro Kuroda; Saori Morota; Go Hirabayashi; Nagao Ishii; Futoshi Shibasaki; Yukiho Ikeda; Magnus J Hansson; Eskil Elmér
Journal:  J Anesth       Date:  2008-08-07       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.